Profile of Group

Tongshantang Medical Investment Group is developed from Shijiazhuang Kidney Disease Hospital. Five large hospital owned by it have established platform of high quality health management services through 30 years’ development. And in these years, they remain committed to the specialized, scale and scientific development, laying a solid foundation of development for the Group. The Group mainly focuses on the construction and operation of health industries at home and abroad, involving rehabilitation of kidney disease, blood disease, tumor and other diseases, production and sales of Mai Kang Misture and health drinks like Xitianfu, etc. It owns Beijing Tongshantang Hospital of Traditional Chinese Medicine, Shanghai Anzhen Hospital, Shijiazhuang Kidney Disease Hospital, Xingtai No.4 Hospital, Jiangsu Eastern Greenland Hospital and Shijiazhuang Shentong Pharmaceutical Limited Company,etc. In these years, the Group devotes itself to exploring a mode of operation and management of hospitals. Because of its accurate diagnosis and good treatment effect, optimized medical service and in-depth market promotion, it was become one of the medical brands with positive social influence in China. And so far it has provide optimized medical service for over 100000 patients from 148 countries.